Contract W81XWH15C0048
Westat, Inc. · Department Of Defense · March 23, 2015
Westat, Inc. was awarded a federal contract by Department Of Defense (Defense Health Agency) on March 23, 2015 for $22.21 million of work in research and development in biotechnology. Performance is in Rockville, MD. It was awarded under full and open competition. The contract has been modified 26 times since the base award It uses cost-plus contract pricing. The most recent modification was on August 28, 2025.
Contract details
- PIID
- W81XWH15C0048
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- R&D- Medical: Other (Advanced Development)
- Place of performance
- Rockville, MD
- First action
- March 23, 2015
- Latest action
- August 28, 2025
Description
THIS REQUIREMENT IS FOR COMMERCIALIZATION OF FREEZE DRIED PLASMA PRODUCT.
Modification timeline
-
August 28, 2025Mod P00026$-534.1K
-
February 11, 2025Mod P00025FREEZE DRIED PLASMA CLINICAL TRIAL FOR BLA RESUBMISSION.$4.08M
-
July 29, 2024Mod P00024FREEZE DRIED PLASMA CLINICAL TRIAL FOR BLA RESUBMISSION.$2.47M
-
June 24, 2024Mod P00023PERFORMANCE OF GOOD PRACTICES COMPLIANT TRIALS OF FREEZE-DRIED PLASMA FOR FOOD AND DRUG ADMINISTRATION LICENSURE.$0
-
August 8, 2023Mod P00022PERFORMANCE OF GOOD PRACTICES COMPLIANT TRIALS OF FREEZE DRIED PLASMA FOR FOOD AND DRUG ADMINISTRATION LICENSURE$239.8K
-
December 9, 2022Mod P00021REGULATORY/PM/ADMIN & PHASE I (C.2.2.)$0
-
December 2, 2022Mod P00020REGULATORY/PM/ADMIN & PHASE I (C.2.2.)$0
-
November 15, 2022Mod P00019REGULATORY/PM/ADMIN & PHASE I (C.2.2.)$0
-
May 9, 2022Mod P00018REGULATORY/PM/ADMIN & PHASE I (C.2.2.)$5.26M
-
March 4, 2022Mod P00017REGULATORY/PM/ADMIN & PHASE I (C.2.2.)$-1.73M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $3.00M |
| Inbios International Inc | Department Of Defense | September 22, 2025 | $25.66M |
| Dynport Vaccine Company Llc | Department Of Defense | September 12, 2025 | $117.63M |
| Deka Integrated Solutions Corp | Department Of Defense | August 25, 2025 | $8.85M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81XWH15C0048?
Contract W81XWH15C0048 is a federal contract awarded to Westat, Inc. by Department Of Defense on March 23, 2015 for $22.21 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 26 times since the base award.
Who won contract W81XWH15C0048?
Westat, Inc. won contract W81XWH15C0048 from Department Of Defense.
How much is contract W81XWH15C0048 worth?
Contract W81XWH15C0048 has obligated $22.21 million to date, with a total potential value of $28.60 million if all options are exercised.